Simultaneous whole body 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with 18F-fluorodeoxyglucose positron emission tomography computed tomography
Pugmire B, Guimaraes A, Lim R, Friedmann A, Huang M, Ebb D, Weinstein H, Catalano O, Mahmood U, Catana C, Gee M. Simultaneous whole body 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging for evaluation of pediatric cancer: Preliminary experience and comparison with 18F-fluorodeoxyglucose positron emission tomography computed tomography. World Journal Of Radiology 2016, 8: 322-330. PMID: 27028112, PMCID: PMC4807342, DOI: 10.4329/wjr.v8.i3.322.Peer-Reviewed Original ResearchPositron emission tomography-computed tomographyDiffusion-weighted imagingMalignant lesionsPediatric oncology patientsPET-MRIMagnetic resonance imagingPositron emission tomographyBenign lesionsPositron emission tomography-computed tomography examinationFDG maximum standardized uptake valueMinimum apparent diffusion coefficientMaximum standardized uptake valueEmission tomography-computed tomographyOncology patientsWhole-body diffusion-weighted imagingHealth Insurance Portability and Accountability Act-compliantStandard department protocolDetection of malignant lesionsEmission tomographyResonance imagingStandardized uptake valuePositron emission tomography magnetic resonance imagingSingle-center studySuspected cancer diagnosisEPI diffusion-weighted imaging